Godavari Biorefineries Secures Chinese Patent for Antiviral Compounds
Godavari Biorefineries has been granted a Chinese patent for compounds that inhibit V-ATPase activity, used in medicaments to treat viral infections. The patent, authorized on September 15, 2026, was originally filed in May 2021. Following the announcement, the company's stock rose nearly 12%. Godavari Biorefineries specializes in bio-based chemicals and ethanol production and recently reported a net loss of Rs 19.32 crore for Q1 June 2026, with a 4.62% increase in net sales year-on-year.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (57/100). Lens Score 33/100.
Outlets measured: businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–62/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
businessstandard broke this story on 16 Sept, 05:37 am. Other outlets followed.
- 1businessstandard16 Sept, 05:37 amGodavari Biorefineries jumps on bagging Chinese patent for antiviral compound
- 2businessstandard16 Sept, 06:07 amGodavari Biorefineries receives Chinese patent for use of compounds for treatment of viral infection
Who's involved
Institutions and figures named across source coverage.
Story context
- Category
- Business
- Location
- China
- Sources analysed
- 2
- Last analysed
- 16 Sept 2026
- Key entities
- Godavari BiorefineriesChinaPatentMedicationChemical substanceIndian rupeeViral diseaseUnited States Patent and Trademark OfficePatent applicationAxis powersStockKanpur